India’s drug regulator eyes lighter oversight, more AI to boost efficiency
By Rishika Sadam NEW DELHI (Reuters) -India’s drug regulator plans to ease processes, set fixed approval timelines and explore artificial intelligence to improve execution, its chief said on Thursday. “We’re trying to increase our efficiency, cutting down on regulations so that we create more and more resources within our system,” the Central Drugs Standard Control …
India’s drug regulator eyes lighter oversight, more AI to boost efficiency Read More »










